Address
One Kendall Square
Cambridge, MA 02139-1562
United States of America (the)
Phone
781-315-4600
Website
Sector
Healthcare
Industry
Biotechnology
Employees
112
First IPO Date
October 03, 2019
| Name | Title | Pay | Year Born |
| Ram Aiyar | Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director | 852,656 | 1978 |
| Jeffrey Cerio | Senior Vice President, General Counsel & Corporate Secretary | 587,500 | N/A |
| Loic Vincent | Chief Scientific Officer | 642,518 | N/A |
| Andrew Fraley | Co-Founder & Advisor | 0 | N/A |
| Joshua Rosenthal | Co-Founder & Advisor | 0 | N/A |
| Gaozhong Zhu | SVP of Chemistry, Manufacturing and Controls & Technical Operations | 0 | N/A |
| Oliver Dolan | Senior Vice President of Finance & Principal Accounting Officer | 0 | 1983 |
| Todd Chappell | Chief Operating Officer | 0 | 1973 |
| Stephanie Engels | Chief People Officer | 0 | N/A |
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.